483
The New York Fertility CenterFDA 483 - The New York Fertility Center - June 15, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The New York Fertility Center in Flushing, NY, received a Form 483 for significant deficiencies in its reproductive human tissue operations. The inspection revealed failures in determining oocyte donor eligibility based on screening and testing, including issues with documentation and risk factor assessment. Additionally, the firm's standard operating procedures were found to be inadequate, and non-FDA-cleared tests were used for communicable disease screening.
Open in Dashboard
ID · b81459f2-8f35-451a-930c-96e93755dfb6